Enveric Biosciences (ENVB)
NASDAQ:ENVB
US Market

Enveric Biosciences (ENVB) Financial Statements

Compare
502 Followers

Enveric Biosciences Financial Overview

Enveric Biosciences's market cap is currently $3.16M. The company's EPS TTM is $-21.334; its P/E ratio is ―; Enveric Biosciences is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-3.45. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -408.03K$ -435.20K$ -681.61K$ -120.87K
Operating Income$ -9.63M$ -16.45M$ -27.42M$ -64.62M$ -5.62M
EBITDA$ -9.25M$ -16.85M$ -19.63M$ -63.97M$ -6.30M
Net Income$ -9.57M-$ -18.47M$ -48.98M$ -6.39M
Balance Sheet
Cash & Short-Term Investments$ 2.24M$ 2.29M$ 17.72M$ 17.36M$ 1.58M
Total Assets$ 3.08M$ 4.30M$ 19.55M$ 26.72M$ 4.10M
Total Debt$ 0.00$ 0.00$ 63.82K$ 176.30K$ 0.00
Net Debt$ -2.24M$ -2.29M$ -17.66M$ -17.18M$ -1.58M
Total Liabilities$ 1.49M$ 2.34M$ 4.00M$ 4.41M$ 681.25K
Stockholders' Equity$ 1.59M$ 1.96M$ 14.67M$ 22.31M$ 3.42M
Cash Flow
Free Cash Flow$ -7.73M$ -14.10M$ -17.73M$ -12.32M$ -3.93M
Operating Cash Flow$ -7.73M$ -14.09M$ -17.15M$ -11.46M$ -3.89M
Investing Cash Flow$ 0.00$ 11.67K$ -584.16K$ 2.19M$ -44.14K
Financing Cash Flow$ 7.67M$ -1.34M$ 18.18M$ 24.90M-
Currency in USD

Enveric Biosciences Earnings and Revenue History

Enveric Biosciences Debt to Assets

Enveric Biosciences Cash Flow

Enveric Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis